Chronic Kidney Disease – Mineral Bone Disorder: Implications for Cardiac Outcomes (An Application-Based Activity)

This professional educational activity will address the common medical problem of CKD-MBD and the implications for cardiac outcomes. Content will review new data related to CKD-MBD published since the 2009 KDIGO guideline on CKD-MBD. Strategies to improve patient adherence and the implications of calcium levels in CKD will also be presented. Finally, the relationship between CKD-MBD and CVD and the opportunity to improve treatment and develop strategies to improve patient management and outcomes will be explored. A case study approach will facilitate application of learning to clinical practice. 

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Recall new data on the optimal management of patients with chronic kidney disease-mineral bone disorder (CKD-MBD) published since the KDIGO guideline.
  • Detect problems related to patient adherence through recognition of patient challenges and strategies to improve adherence, including individualized phosphate therapy and management.
  • Determine the implications of calcium imbalance in CKD and the potential role of calcium versus non-calcium phosphate binders.
  • Examine the relationship between CKD-MBD and cardiovascular disease (CVD) to improve treatment and develop strategies to improve patient management and outcomes.
PLEASE NOTE: YOU MUST LOGIN OR CREATE AN ACCOUNT BEFORE ENROLLING IN THIS EDUCATIONAL ACTIVITY. 

Once you're logged in the "ADD TO CART" button can be found at the bottom of this webpage.

Target Audience

  • Physicians
  • Family Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Nurses
  • Dietitians
  • Pharmacists
Accreditation/Designation of Credit Statements:

Physician
The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Kidney Foundation designates this enduring for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Family Physician

This enduring material activity Chronic Kidney Disease – Mineral Bone Disorder: Implications for Cardiac Outcomes has been reviewed and is acceptable for up to 1.0 Prescribed credit(s) by the American Academy of Family Physicians.  Term of credit begins December 16, 2016.  Term of approval is for one year from this date.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 
Physician Assistant 

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.

Nurse Practitioner 

This activity is approved for 1.0 contact hours of continuing education (which includes 0.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 16112435.

This activity was planned in accordance with AANP CE Standards and Policies. 

Nurse

The National Kidney Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hours of continuing nursing education (includes 0.0 contact hours in the area of pharmacology). 

Dietitian 

The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

Pharmacist

The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.  Reading the learning objectives and faculty disclosures; participating in the entire application-based activity, completing the pre-test, active learning activity, post-test (minimum score of 70% required; may be taken up to 3 times) and activity evaluation; estimating duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits.  This activity has been assigned ACPE Universal Activity Number 0016-9999-16-109-H01-P for 1.0 contact hours (0.10 CEUs).  All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days.  For more information and to set up your e-Profile visit:  www.MyCPEmonitor.net.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit.  The estimated time for completion is 1.0 hour.    

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.00 AAFP Prescribed Credits
  • 1.00 AANP Contact Hours
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants
  • 1.00 CDR CPEUs
Course opens: 
12/16/2016
Course expires: 
12/16/2017
Cost:
$0.00
Rating: 
4
Faculty Disclosures:

Geoffrey Block, MD
Director of Research
Denver Nephrologists
Denver, CO
Disclosure: Received consulting fees from Amgen in the area of SHPT, Keryx in the area of MBD, Akebia in the area of anemia, AstraZeneca in the area of anemia, and Relypsa in the area of hyperkalemia.  Received honoraria and travel expenses from Kirin for a self-made presentation on MBD.

Kamyar Kalantar-Zadeh, MD, MPH, PhD
Professor of Medicine, Pediatrics, and Public Health & Epidemiology
University of California Irvine School of Medicine
Irvine, CA
Disclosure: Received honoraria and/or support from Abbott, Abbvie, Alexion, Amgen, ASN (American Society of Nephrology), Astra-Zeneca, Aveo, Chugai, DaVita, Fresenius, Genentech, Haymarket Media, Hofstra Medical School, IFKF (International Federation of Kidney Foundations), ISH (International Society of Hemodialysis), International Society of Renal Nutrition & Metabolism (ISRNM), JSDT (Japanese Society of Dialysis Therapy), Hospira, Kabi, Keryx, Novartis, NIH (National Institutes of Health), NKF (National Kidney Foundations), Pfizer, Relypsa, Resverlogix, Sandoz, Sanofi, Shire, Vifor, UpToDate, ZS-Pharma.

Planning Committee Disclosures:

Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA
Disclosure: Has no financial relationships with commercial interest(s).

Kim Deaver, MSN, RN, CNN
Dialysis Nurse Manager
University of Virginia
Charlottesville, VA
Disclosure: Has no financial relationships with commercial interest(s).

Amy Pai, PharmD
Associate Professor
University of Michigan College of Pharmacy
Ann Arbor, MI
Disclosure: Received a consulting fee from AMAG Pharmaceuticals, and an honoraria from AstraZeneca for her role on an advisory board.

Lynn Puma, LCSW
Pediatric Transplant Social Worker
Carolinas HelathCare System
Part-Time Faculty
UNC Charlotte
Charlotte, NC
Disclosure: Has no financial relationships with commercial interest(s).

Deborah Brommage, MS, RD, CSR, CDN
Senior Scientific Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Anna Okoniewski
CME/CE Activities Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Jose F. Bernardo, MD, MPH, FASN
Associate Professor of Medicine
Staff Nephrologist
University of Pittsburgh School of Medicine, UPMC
Pittsburgh, PA
Disclosure: Has no financial relationships with commercial interest(s).

Beverly Benmoussa, MSN, FNP-BC
Nurse Practitioner
University of Michigan - Transplant Nephrology
Ann Arbor, MI
Disclosure: Has no financial relationships with commercial interest(s).

Janelle Gonyea, RDN, LD, FNKF
Clinical Dietitian
Mayo Clinic
Rochester, MN
Disclosure: Has no financial relationships with commercial interest(s).

Sheila Allen, PharmD    
Clinical Assistant Professor    
Pharmacy Practice
UIC College of Pharmacy
Chicago, IL
Disclosure: Has no financial relationships with commercial interest(s).

Isaac Cha, PharmD    
Clinical Assistant Professor    
Pharmacy Practice
UIC College of Pharmacy
Chicago, IL
Disclosure: Holds stock in Baxter International, Inc.; Aetna Gilead Sciences, Inc.; and Thermo Fisher.

Sandra Cuellar Puri, PharmD    
Clinical Assistant Professor    
Pharmacy Practice
UIC College of Pharmacy
Chicago, IL
Disclosure: Is a member of the speaker’s bureau for Merck, Celgene, and BMS.

Larry Danziger, PharmD    
Professor    
Pharmacy Practice
UIC College of Pharmacy
Chicago, IL
Disclosure: Received a grant from Medicines Company; is a consultant for Allergan, Astellas, and Merck; and holds stock in Pfizer.
                                        
Edith Nutescu, PharmD    
Associate Professor    
Pharmacy Systems Outcomes and Policy    
UIC College of Pharmacy
Chicago, IL
Disclosure: Received a grant from NIH/NHLBI, ASHP Foundation, and Roche.
                    
Francis Schlemmer, PhD    
Associate Professor, Emeritus    
Biopharmaceutical Sciences
UIC College of Pharmacy
Chicago, IL
Disclosure: Has no financial relationships with commercial interest(s).
    
Nicole Soldat
Continuing Professional Education Meeting Planner
UIC College of Pharmacy
Chicago, IL
Disclosure: Holds stock in Acadia Pharmaceuticals, Inc., and Relypsa, Inc.

Rosalyn P. Vellurattil, PharmD, CDE 
Continuing Pharmacy Education Administrator
UIC College of Pharmacy
Chicago, IL
Disclosure: Has no financial relationships with commercial interest(s).


Supported by an educational grant from Sanofi US.

Available Credit

  • 1.00 AAFP Prescribed Credits
  • 1.00 AANP Contact Hours
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 1.00 Attendance
  • 1.00 Category I Credit for Physician Assistants
  • 1.00 CDR CPEUs

Accreditation Period

Course opens: 
12/16/2016
Course expires: 
12/16/2017

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals